Monoethyl-glycinexylidide (MEGX) as an early predictor of liver dysfunction in severe sepsis.

dc.contributor.author	K, Van Ackern
dc.contributor.author	Akpir, Kutay
dc.contributor.author	ESEN, Figen
dc.contributor.author	Erdem, Tamer Lütfi
dc.contributor.author	ÇAKAR, Nahit
dc.contributor.author	TELCİ, Lütfü
dc.contributor.author	m, quintel
dc.date.accessioned	2021-03-02T20:49:46Z
dc.date.available	2021-03-02T20:49:46Z
dc.identifier.citation	ESEN F., Erdem T. L. , ÇAKAR N., m q., TELCİ L., Akpir K., K V. A. , "Monoethyl-glycinexylidide (MEGX) as an early predictor of liver dysfunction in severe sepsis.", clin critical care, cilt.8, ss.260-266, 1997
dc.identifier.other	vv_1032021
dc.identifier.other	av_03e44d6f-0ca7-4265-b015-d906618b22fd
dc.identifier.uri	http://hdl.handle.net/20.500.12627/8558
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.title	Monoethyl-glycinexylidide (MEGX) as an early predictor of liver dysfunction in severe sepsis.
dc.type	Makale
dc.relation.journal	clin critical care
dc.contributor.department	, ,
dc.identifier.volume	8
dc.identifier.startpage	260
dc.identifier.endpage	266
dc.contributor.firstauthorID	283219

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.